Search - tctmd.com

Displaying 1 - 20 of 138

Sort: Relevancy | Date

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Caitlin E. Cox

October 16, 2025

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Todd Neale

December 29, 2023

Advertisement

HF Care Differs Among Asian Subgroups in the US

Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

April 2025 Dispatch for the CV Team

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

October 2024 Dispatch for the CV Team

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

July 2024 Dispatch for the CV Team

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

June 2024 Dispatch for the CV Team

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

STRONG-HF: Higher GDMT Doses Equal Better Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content